May 5, 2020 / 11:18 AM / a month ago

Alexion to buy Portola Pharmaceuticals in $1.41 bln deal

May 5 (Reuters) - Alexion Pharmaceuticals Inc. on Tuesday agreed to buy Portola Pharmaceuticals Inc in a deal that values the U.S. drug developer at $1.41 billion.

Alexion would pay $18 per Portola share in cash, a premium of 132% to Portola’s last closing price, the companies said. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below